N. V. Muliarova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
N. V. Muliarova has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- A. Yu. Smirnova
Almazov National Medical Research Centre, Ministry of Health of Russia
1 shared publication - Igor A. Kelmanson
Almazov National Medical Research Centre
1 shared publication - Irina Leorovna Nikitina
Almazov National Medical Research Centre
1 shared publication - Irina V. Vinyarskaya
National Medical Research Center for Children’s Health
1 shared publication - N. G. Goikalov
Almazov National Medical Research Centre, Ministry of Health of Russia
1 shared publication - Olga G. Zheludkova
V.F. Voyno-Yasenetsky Scientific and Practical Center of Specialized Medical Care for Children
1 shared publication
Latest Publications
- Open Access
- 12 August 2026
- Published by OOO Grafika in Russian Journal of Pediatric Hematology and Oncology
- Vol. 13 (2) , 41-53
Assessment of quality of life in patients who underwent antineoplastic therapy for central nervous system malignancies in childhood
Background . According to international statistics tumors of the central nervous system take a leading position in the structure of childhood cancer morbidity. The use of a multimodal strategy of anticancer therapy today allows achieving a high level of long-term survival, but often with severe variants of long-term toxicity. The study of the health status of cured patients and assessment of their quality of life (QOL) in the aspects of searching for controllable factors to reduce treatment toxicity is a pressing problem in pediatric oncology and pediatrics. Materials and methods . The study included 76 patients with a confirmed diagnosis of medulloblastoma (93.4 %) or atypical teratoid rhabdoid tumor (6.6 %), established at the age of up to 18 years, for which antitumor therapy was carried out. For assess to QOL, the Health Utilities Index questionnaire of Mark 2 and 3 versions (HUI2 and HUI3) was used, consisting of 15 questions. The impact of disease burden (histological tumor type, stage and type (primary tumor/relapse) of the disease, inclusion of high-dose chemotherapy, volume of radiation therapy and surgery) on the health attribute scores was analyzed. Results . The median age of patients at the time of the survey was 11.7 years with a median interval after completion of specific treatment of 6.4 years. Respondents to the survey were patients’ parents (n = 37; 48.7 %) and/or the attending physician monitoring the child (n = 39; 51.3 %). The average time spent on filling out the questionnaire was 8.0 ± 3.0 min. The frequency of a decrease in the levels of health attributes according to the HUI2 and HUI3 systems were 47% and 53 %, corresponding to mild (66 % and 62 %), moderate (27 % and 26 %) and severe (7 % and 12 %) severity of disorders. Functional health disorders mostly concerned such QOL components as cognitive abilities, emotions, sensation, mobility, varying from moderate to severe. Metastatic stage of the tumor had statistically significant negative impact on mobility and ambulation (p = 0.02), self-care (p = 0.05) and dexterity (p = 0.01); patients with disease recurrence showed decreased cognition (p = 0.03) and emotional status (p = 0.002); the use of craniospinal irradiation was also associated with decreased cognitive abilities (p = 0.04). Conclusions . Assessment of patients’ QOL using the HUI2 and HUI3 questionnaire is a simple and accessible method for routine use in clinical practice. Statistically significant deviations in health attributes were registered in children who underwent antitumor therapy for medulloblastoma or atypical teratoid rhabdoid tumor, while unfavorable risk factors were disease recurrence, metastatic stage of the disease and radiation therapy in the CSI. It is important to note that despite the high percentage of recorded deviations in the assessed health attributes, more than half of them corresponded to mild to moderate impairments. The most vulnerable components were the motor sphere and cognitive abilities. Given the small sample size, it is impossible to speak about a high degree of significance of the obtained results, which requires continuation of research in the specified cohort of patients, however, they coincide with international literature data. It should also be noted that the questionnaire provides an assessment of the health status of patients in a specific period, while it can change significantly over time and against the background of numerous factors, thereby determining the need for dynamic monitoring.
- 12 August 2026
- Published by OOO Grafika in Russian Journal of Pediatric Hematology and Oncology
- Vol. 13 (2) , 41-53
Open AccessAssessment of quality of life in patients who underwent antineoplastic therapy for central nervous system malignancies in childhood
Background . According to international statistics tumors of the central nervous system take a leading position in the structure of childhood cancer morbidity. The use of a multimodal strategy of anticancer therapy today allows achieving a high level of long-term survival, but often with severe variants of long-term toxicity. The study of the health status of cured patients and assessment of their quality of life (QOL) in the aspects of searching for controllable factors to reduce treatment toxicity is a pressing problem in pediatric oncology and pediatrics. Materials and methods . The study included 76 patients with a confirmed diagnosis of medulloblastoma (93.4 %) or atypical teratoid rhabdoid tumor (6.6 %), established at the age of up to 18 years, for which antitumor therapy was carried out. For assess to QOL, the Health Utilities Index questionnaire of Mark 2 and 3 versions (HUI2 and HUI3) was used, consisting of 15 questions. The impact of disease burden (histological tumor type, stage and type (primary tumor/relapse) of the disease, inclusion of high-dose chemotherapy, volume of radiation therapy and surgery) on the health attribute scores was analyzed. Results . The median age of patients at the time of the survey was 11.7 years with a median interval after completion of specific treatment of 6.4 years. Respondents to the survey were patients’ parents (n = 37; 48.7 %) and/or the attending physician monitoring the child (n = 39; 51.3 %). The average time spent on filling out the questionnaire was 8.0 ± 3.0 min. The frequency of a decrease in the levels of health attributes according to the HUI2 and HUI3 systems were 47% and 53 %, corresponding to mild (66 % and 62 %), moderate (27 % and 26 %) and severe (7 % and 12 %) severity of disorders. Functional health disorders mostly concerned such QOL components as cognitive abilities, emotions, sensation, mobility, varying from moderate to severe. Metastatic stage of the tumor had statistically significant negative impact on mobility and ambulation (p = 0.02), self-care (p = 0.05) and dexterity (p = 0.01); patients with disease recurrence showed decreased cognition (p = 0.03) and emotional status (p = 0.002); the use of craniospinal irradiation was also associated with decreased cognitive abilities (p = 0.04). Conclusions . Assessment of patients’ QOL using the HUI2 and HUI3 questionnaire is a simple and accessible method for routine use in clinical practice. Statistically significant deviations in health attributes were registered in children who underwent antitumor therapy for medulloblastoma or atypical teratoid rhabdoid tumor, while unfavorable risk factors were disease recurrence, metastatic stage of the disease and radiation therapy in the CSI. It is important to note that despite the high percentage of recorded deviations in the assessed health attributes, more than half of them corresponded to mild to moderate impairments. The most vulnerable components were the motor sphere and cognitive abilities. Given the small sample size, it is impossible to speak about a high degree of significance of the obtained results, which requires continuation of research in the specified cohort of patients, however, they coincide with international literature data. It should also be noted that the questionnaire provides an assessment of the health status of patients in a specific period, while it can change significantly over time and against the background of numerous factors, thereby determining the need for dynamic monitoring.